- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 909-923 of
1,371 results
1130 Exhibit: Supplemental Declaration of Robert D Stoner, PhD
Document
IPR2016-01582, No. 1130-293 Exhibit - Supplemental Declaration of Robert D Stoner, PhD (P.T.A.B. May. 12, 2017)
|
|
Cite Document
2030 Exhibit: JSN 2030 Clinical Cancer Research Peer Review letter to Judson, dat...
Document
IPR2016-01582, No. 2030-111 Exhibit - JSN 2030 Clinical Cancer Research Peer Review letter to Judson, dated May 12, 2003 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2006 Exhibit: Standing Protective Order
Document
IPR2016-01582, No. 2006-86 Exhibit - Standing Protective Order (P.T.A.B. Nov. 16, 2016)
|
|
Cite Document
2053 Exhibit: JSN 2053 Lara and Meyers, ¿¿¿Treatment Options in Androgen Indepe...
Document
IPR2016-01582, No. 2053-132 Exhibit - JSN 2053 Lara and Meyers, ¿¿¿Treatment Options in Androgen Independent Prostate Cancer,¿¿¿ Cancer Investigation, 172137 144 1999 (P.T.A.B. Mar. 17...
|
|
Cite Document
2079 Exhibit: JSN 2079 Carducci et al, ¿¿¿A Phase 3 Randomized Controlled Trial of...
Document
IPR2016-01582, No. 2079-158 Exhibit - JSN 2079 Carducci et al, ¿¿¿A Phase 3 Randomized Controlled Trial of the Efficacy and Safety of Atrasentan in Men With Metastatic Hormone refractory Pr...
|
|
Cite Document
2038 Exhibit: JSN 2038 Declaration of Matthew Rettig, MD
Document
IPR2016-01582, No. 2038-117 Exhibit - JSN 2038 Declaration of Matthew Rettig, MD (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2025 Exhibit: JSN 2025 Conde and Aronson, ¿¿¿Risk factors for male osteoporosis,¿...
Document
IPR2016-01582, No. 2025-106 Exhibit - JSN 2025 Conde and Aronson, ¿¿¿Risk factors for male osteoporosis,¿¿¿ Urologic Oncology, 21380 383 2003 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1009 Exhibit: Harrisons Principles of Internal Medicine 2005
Document
IPR2016-01582, No. 1009-8 Exhibit - Harrisons Principles of Internal Medicine 2005 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2015 Exhibit: JSN 2015 Declaration of Dr Marc Garnick
Document
IPR2016-01582, No. 2015-96 Exhibit - JSN 2015 Declaration of Dr Marc Garnick (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2113 Exhibit: JSN 2113 Public Citizen Press Room Release ¿¿¿ ¿¿¿Antifungal Treatme...
Document
IPR2016-01582, No. 2113-190 Exhibit - JSN 2113 Public Citizen Press Room Release ¿¿¿ ¿¿¿Antifungal Treatment Should Be Taken Off the Market, Public Citizen Tells FDA,¿¿¿ dated February 24, 2...
|
|
Cite Document
2168 Exhibit: JSN 2168 Zytiga Label 2011
Document
IPR2016-01582, No. 2168-237 Exhibit - JSN 2168 Zytiga Label 2011 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2017 Exhibit: JSN 2017 Declaration of Scott Serels, MD, filed on Dec 4, 2015 in Am...
Document
IPR2016-01582, No. 2017-98 Exhibit - JSN 2017 Declaration of Scott Serels, MD, filed on Dec 4, 2015 in Amerigen Pharmaceuticals Ltd v Janssen Oncology, Inc, IPR2016 00286 (P.T.A.B. Mar. ...
|
|
Cite Document
1077 Exhibit: Declaration of Robert D Stoner, PhD
Document
IPR2016-01582, No. 1077-80 Exhibit - Declaration of Robert D Stoner, PhD (P.T.A.B. Aug. 16, 2016)
|
|
Cite Document
1007 Exhibit: Tannock 2004
Document
IPR2016-01582, No. 1007-6 Exhibit - Tannock 2004 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2157 Exhibit: JSN 2157 Sweeney, ¿¿¿ECOG 3805 CHAARTED ¿¿¿ ChemoHormonal T...
Document
IPR2016-01582, No. 2157-226 Exhibit - JSN 2157 Sweeney, ¿¿¿ECOG 3805 CHAARTED ¿¿¿ ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prosta...
|
|
Cite Document
